Financial Performance & Position - MC Group's cash and short-term investments stand at THB 1,984 million[25], with a zero-debt position[35], indicating financial resilience - Online sales experienced a significant year-over-year growth of +69%[28], shifting the online sales contribution to 17% of total sales[28] - The company maintains a high gross margin while controlling expenses, with gross profit increasing by +2.0%[30] and SG&A to sales decreasing to 42.4%[30] - Net profit margin increased to 18.0%[33], with EBIT increasing by +3.5%[33] - Inventory levels are controlled lower than FY2024[35] Business Strategy & Operations - The company is transitioning from a denim-focused brand to a lifestyle brand, with denim products accounting for 33%[12] and non-denim products for 67%[12] of the product portfolio - MC Group has a fully integrated supply chain[14], allowing for business flexibility and high margin maintenance[17] - The company aims to expand brick-and-mortar stores in potential locations while investing wisely in e-commerce[54] - CRM is identified as a profit center, with a focus on enhancing the royalty program and increasing customer engagement[77] Product Portfolio - The product portfolio mix shows Denim at 42% in FY23, 34% in FY24 and 33% in FY25[49], Non-Denim at 45% in FY23, 49% in FY24 and 47% in FY25[49], and Accessories at 13% in FY23, 17% in FY24 and 20% in FY25[49]

Acquisition Overview - NRW has agreed to acquire 100% of Fredon Industries [20] - The enterprise value is up to $200 million, with an economic effective date of July 1, 2025 [20] - The acquisition multiple is 52x EV/EBIT, assuming maximum Earn Out Consideration is paid [20] - Fredon is expected to generate revenue of approximately $840 million and EBIT of approximately $40 million in FY26 before synergies [20] - The acquisition is funded from existing corporate facilities, including $122 million in initial cash and an earn-out of $45 million to $60 million [20] Fredon's Financial Performance - Fredon generated $840 million in revenue and a normalized EBIT of $386 million in FY25 [16, 20] - Approximately $840 million of revenue is scheduled for delivery in FY26 [17] - Fredon has a pipeline of $36 billion, with submitted tenders of approximately $2 billion [42] Strategic Alignment - The acquisition delivers a 4th pillar "EMIT" aligning with NRW's strategy to grow through expanding the service offering [18] - Fredon has generated approximately 70% of revenue from customers with relationships of over 20 years [34] - NRW expects FY26 full-year revenue to be in excess of $34 billion and EBITA to be between $218 million to $228 million, excluding the Fredon acquisition [51]

Offer Summary - Black Rock Mining is undertaking a capital raising of A$12 million through a two-tranche placement targeting A$10 million and a share purchase plan (SPP) targeting up to A$2 million[41] - The offer price is A$0.021 per New Share, representing a 23.6% discount to the last trade price of A$0.0275 on 28 August 2025 and a 24.8% discount to the 5-day VWAP of A$0.0279 as at 28 August 2025[41] - The company intends to offer one new option for every one share subscribed under the Offer, with an exercise price of A$0.03 and expiry 2 years from issue[41] Project Funding and Economics - The Mahenge Graphite Project has a post-tax NPV10 of US$1.4 billion (A$2.1 billion)[26] - US$254 million of funding is in place, subject to conditions, including US$204 million from DBSA, IDC, and CRDB and up to US$50 million from POSCO[26, 31] - Module 1 production is forecast at 89ktpa with a capex of US$231 million, and steady-state production (4 x 1Mtpa) is 347ktpa[61] Company Overview - POSCO Group holds an 8.6% stake in Black Rock Mining[30] - Black Rock has binding offtake agreements in place with POSCO for 100% of the fines production for Mahenge Module 1 and, if and when built, Module 2[47] - POSCO approved construction of its own US$277 million SPG plant in Korea, with first production due in 2027[46]

Bucharest, 1 September 2025 Presentation of Electrica H1 2025 Financial Results (Acc. IFRS-EU) The results presented are based on the consolidated financial statements prepared in accordance with the International Financial Reporting Standards (IFRS-EU). This document was prepared by Electrica for the presentation of H1 2025 financial results and has an informative nature. This presentation is not an offer, an invitation or recommendation to trade the securities issued by Electrica. Content Electrica Group' ...

For personal use only Corporate Presentation HFfree Vertically Integrated BAM Delivers Industry -Leading Low Cost September 2025 Disclaimer Securities Disclaimer This document is for informational purposes only and does not constitute an offer to sell, or solicit to purchase, any securities. Such offer can be made only through proper subscription documentation and only to investors meeting strict suitability requirements. Any failure to comply with these restrictions may constitute a violation of applicable ...

AstraZeneca Ambition & Strategy - AstraZeneca aims to achieve $80 billion in total revenue by 2030, driven by its existing portfolio and the launch of new medicines [7, 8] - The 2030 total revenue ambition is not dependent on future mergers and acquisitions [8] - Cardiometabolic diseases are a key area of focus, with the goal of transforming care and addressing unmet needs [17] Baxdrostat Clinical Trial (BaxHTN) Results - The Phase III BaxHTN trial demonstrated that baxdrostat, at 1mg and 2mg doses, led to placebo-adjusted reductions in seated systolic blood pressure (SBP) of 8.7 mmHg and 9.8 mmHg respectively after 12 weeks in patients with uncontrolled or resistant hypertension [63] - In the BaxHTN trial, 73% of participants had resistant hypertension, while 27% had uncontrolled hypertension [43] - Serum aldosterone concentration decreased from baseline to Week 12 with baxdrostat 1mg by 60% (from 7.9 to 3.2 ng/dL) and with baxdrostat 2mg by 65% (from 7.2 to 2.5 ng/dL) [55] - In the BaxHTN trial, rates of confirmed serum potassium >6.0 mmol/L were low, at 1% in both baxdrostat groups [63] Baxdrostat Market Opportunity - Baxdrostat has a potential of $5 billion+ across monotherapy and combination opportunities [69] - There are over 75 million uncontrolled 2L+ hypertension patients ex-US and over 20 million in the US [68]

Financial Performance - Reported revenues for Q2 2025 were $480.1 million[8] - Net profit for Q2 2025 was $77.5 million, or $0.35 per basic and diluted share[10] - Adjusted profit for Q2 2025 was $80.4 million, or $0.36 per basic and diluted share[10] - Declared a cash dividend of $0.36 per share for Q2 2025[8] - Strong liquidity of $844 million in cash and cash equivalents as of June 30, 2025[16] Fleet and Operations - VLCC TCE was $43,100 with 82% contracted[8] - Suezmax TCE was $38,900 with 76% contracted[8] - LR2 / Aframax TCE was $29,300 with 73% contracted[8] - Fleet average cash breakeven rate is $25,900 for the next 12 months[19] - Q2 2025 fleet average opex excluding drydock was $8,100[19] Market Dynamics - Compliant tanker fleet utilization is improving due to compliant oil export growth[30]

Financial Performance - The Group achieved a consolidated pro-forma turnover of RON 1.57 billion in H1 2025, a 20.3% increase compared to H1 2024 [19] - Pro-forma EBITDA increased by 21.2% to RON 234.2 million, with a margin of 16.1% [34] - IFRS Revenues recorded a solid 20% increase, with 16.2% driven by organic growth [50] - Net cash from operating activities declined by 41% compared to the same period last year [60] Acquisitions and Investments - The Group finalized the acquisition of Routine Med Group in Tulcea in February [21] - A majority stake in All Clinic in the Republic of Moldova was acquired in March [21] - The acquisition of Medstar Clinic Group in Cluj-Napoca was announced in June, with 2024 revenues of approximately RON 32 million [22] - The company launched the first AI assistant integrated into its mobile app [25] - The company enhanced its diagnostic infrastructure with the 2nd automated laboratory line in the Group, with an investment of over EUR 2 million [26] - The company acquired the Illumina sequencing technology with an initial investment of EUR 3 million [27] Operational KPIs - Hospitals revenue increased by 37.8% to RON 437.787 million [50] - Clinics revenue increased by 20.3% to RON 586.623 million [50] - Laboratories revenue increased by 18.4% to RON 172.790 million [50]

Financial Performance - Revenues increased by 4% to CA$1,888 million in FY26 Q2 compared to CA$1,811 million in FY25 Q2 [13] - Normalized EBITDA decreased by 9% to CA$213 million in FY26 Q2 [16] - Normalized diluted earnings per share decreased by 10% to CA$0.92 in FY26 Q2 [16] - Free cash flow generation increased by 54% to CA$99 million in FY26 Q2 [16] - Net income increased by 36% to CA$57 million, with diluted earnings per share at CA$0.79 [16] Retail Sales and Market Dynamics - North American Powersports retail sales declined by 11% in FY26 Q2, mainly due to softer trends in PWC and 3WV [16] - North American network inventory is down by 20% [16] - Year-Round Products revenues were up 13%, with revenues reaching CA$1,114 million in FY26 Q2 compared to CA$985 million in FY25 Q2 [37] - Seasonal Products revenues decreased by 13%, with revenues of CA$470 million [46] Guidance and Outlook - The company estimates a tariff impact of approximately CA$90 million for FY26 [65] - The company expects total revenues between CA$8,150 million and CA$8,300 million for FY26 [64] - The company expects net income between CA$430 million and CA$470 million for FY26 [64]

Financial Performance - Total net revenues reached RMB3,331.9 million, a 10.2% year-over-year increase[10] - Non-GAAP net income for Q2 2025 was RMB629.8 million, a 0.1% year-over-year increase[10] - Non-GAAP net income for the first half of 2025 (H1) was RMB1,307.1 million, a 6.8% year-over-year increase[10] - The company has no interest-bearing debt as of June 30, 2025[55] - Net cash provided by operating activities was RMB611 million for the three months ended June 30, 2025[53] Teahouse Network Expansion - The total number of teahouses reached 7,038[10] - There were 357 net new teahouse openings[10] - Greater China teahouses totaled 6,830[12] - Overseas locations totaled 208, with expansion in Malaysia (178), Singapore (16), Indonesia (8), Thailand (5), and the United States (1)[12] User Engagement - The number of registered members reached 206.9 million, a 42.7% year-over-year increase[10] - Orders from registered members who purchased more than twice accounted for 73.9% of orders for the three months ended June 30, 2025[33] - Third-party delivery platform GMV mix was 52.0% for the three months ended June 30, 2025[33]